Hoćete li se vakcinisati protiv korone?

[insomnia]

Mene mjere svakako ne doticu. Ne idem na mjesta niti koristim usluge za koje je potreban negativan test. Ne pada mi na pamet placati 25€ za test koji vazi 24h
Jebavanje u mozak je predvidjeno za ove sa dvije, tri doze

[Fuddo]

Mene mjere svakako ne doticu. Ne idem na mjesta niti koristim usluge za koje je potreban negativan test. Ne pada mi na pamet placati 25€ za test koji vazi 24h
Jebavanje u mozak je predvidjeno za ove sa dvije, tri doze

[Rum]

Razmotrimo za pocetak sta je um zarobljen u zacaranom krugu jedan od najociglednijih primjera je fenomen zabrinutosti,maje vam kaze da ste banovani kao rezultat toga svako automatski pocne da brine o tome
ali posto zabrinutost smanjuje apetit i san to nije dobro za tebe.ali ne mozes prestati da brines ,pa postajes dodatno zabrinut,zato sto se uopste brines.Onda posto je ovo prilicno apsurdno i ljut si na sebe sto to uopste radis,zabrinut si sto se brines ,jer se brines.To je zacarani krug.
Zato sada mozes li dopustiti svom umu da se umiri?Zar nije tesko?Jer um kao da se ponasa poput majmuna,skakuce gore-dolei brblja ...stalno.jednom kada prihvatis misao da ne mozes prestati,a ogroman broj ljudi posveti cjeli zivot drzeci um zaposlenim i osjecaju se uzasno nelagodno u tisini.
Kada si sam,niko nista ne .govori i nemas sta da radis.Postoji ta briga ,taj nedostatak odvracanja pozornosti ostavljen sam sa sobom i onda zelim da pobjegnem od sebe,uvijek zelim da pobjegnem od sebe,zato idem u kino , visim na bosasnkom forumu, zato citam pknjige,zato izlazim sa djevojkama ,bilo sta ili se napijem ili sta god vec.
Ne zelim biti sam sa sobom,osjecam se cudno ,kao da sam skrenuo.Zasto zelis da pobjegnes od sebe?? Sta je tako strasno?Zasto zelis da zaboravis to?Jer si zavisan od misli.
To je droga .Stvaras je razmisljanjem.Kompulsivno razmisljanje koje ide,i ide , i ide...To je navika.Postoji problem u zaustavljanju te aktivnosti.A stvarno je moras zaustaviti ako zelis zadrzati zdrav razum.Jer ako pricam cijelo vrijeme ,ne osjecam sta drugi imaju da kazu,dovescu se u situaciju da necu imati sta da razgovaram,osim vlastitog govora.
I zato na upravo indetican nacin ako razmisljam cijelo vrijeme ,necu imati nista za razmisljanje osim misli.Tako da ako zelis imati nesto za razmisljanje povremeno jednostavno moras prestati da razmisljas.Kako to izvesti???Prvo pravilo je da ni ne pokusavas .Jer ako pokusas ,bices kao neko ko pokusava izravnati uzburkanu vodu peglom.To ce je samo jos vise uzburkati.
Bas kao sto se blatnjavi uzburkani bazen smiri sam kada ga pustis na miru,moras nauciti kako pustiti um na miru.Umirice se sam.

[insomnia]

Za to vrijeme JAR i Bocvana objavile izlazak iz cetvrtog vala pandenije. Strasni Omikron donio je puno manje hospitalizacija nego prethodni a povecanje smrtnosti je marginalno
https://www.lemonde.fr/planete/article/ ... _3244.html

[bosanski migrant]

pa ne bi mi bilo svejedno da umrem od korone ali sam se vise bojao zbog porodice, hodam ko i prije, koliko meni treba, masku nisam stavio 2x zadnja 2 mjeseca, stavim gdje neko zahtjeva, postovao do vakcine i dok roditelji nisu oboljeli sve mjere od marta 2020.
dovoljno od mene, pokazao sam dobru želju da ovo završi za razliku od vas šupaka antimaskaša, antimjeraša, antivaksera a svi se prtrgoste od brige za čovječanstvo dok vam sugrađani umiru masovno od neke gripe, donio odluku koja mi je djelovala logična u epidemiji,

[insomnia]

Kako tacno tebe vakcinisanog ugorzavam ja nevakcinisan?
Pgtv sto je cinjenica da vakcinisani takodje oboljevaju i prenose virus

[insomnia]

Jucer je u cijelom svijetu zabiljezen rekordan broj pozitivnih ali takodje i najnizi broj umrlih od novembra 2020-e. Sve je vise izvjestaja sa svih strana kako je strasni Omikro puno bezazleniji od ostalih sojeva. A sa obzirom da preuzima primat, u Fr npr vec cini preko 60 posto zaraza ovo bi se moglo lagano i privoditi kraju. Naravno sto se tice medicinske strane. Nesto sumnjam da ce vlade ispustiti ovakvu priliku za ukinuti sve ovcama tako da bi ste strane jos dugo mogli biti bocani i strahovati

Ovako se pune bolnice u engleskoj
"Nous avons pas mal de gens qui, par exemple, sont tombés de vélo et se sont cassé un bras. Ils n’ont pas de symptômes, mais, à leur arrivée, ils font un test Covid qui se révèle positif."

lemonde.fr/planete/articl…]
Imamo dosta ljudi koji se povrijede, npr padnu sa bicikla, slome ruku, nemaju nikakvih simptoma ali po dolasku u bolnicu budu pozitivni na testiranju

[bosanski migrant]

Kako tacno tebe vakcinisanog ugorzavam ja nevakcinisan?
Pgtv sto je cinjenica da vakcinisani takodje oboljevaju i prenose virus

To je cisto stvar matematike, ti mene ne ugrozavas nicim

[insomnia]

Halo, klocko, dje ti pobjeda?


Tupko opet pozitivan.
Prvo put se zarazio bez vakcine i “prelezo” na nogama. Drugi put sa vakcinom i “prelezace” haman na isti nacin. Al more putovati i pobjedjivati.

[MunDzi]

Moj muzek danas negativan.

A jeste proklio u izolaciji.

[Venera]

Moj muzek danas negativan.

A jeste proklio u izolaciji.

Opa, tradicija prvog dana u novoj godini neće biti obustavljena.

[MunDzi]

Moj muzek danas negativan.

A jeste proklio u izolaciji.

Opa, tradicija prvog dana u novoj godini neće biti obustavljena.

[insomnia]

More se i pozitivan trpati

[Matan]

U Becu pohvatano par osoba koje su prodavali lazne certifikate o vakcinisanju..
znaci, prijavis se, sve normalno za vakcinu, odes u glavni centar za vakcinisanje,
i kad dodjes u onu kucicu, onoj ili onome das 200 eura, a vakcinu poneses i bacis u smece..
sta se svega nece dosjetiti..

[Taare]

Mene mjere svakako ne doticu. Ne idem na mjesta niti koristim usluge za koje je potreban negativan test.

Znači ne obilaziš pufove

[shark-attack]

https://www.nature.com/articles/s41591-021-01630-0

References
1.
Number of people vaccinated against COVID-19. Our World in Data; https://ourworldindata.org/explorers/co ... untry=~ITA (2021).
2.
Selected adverse events reported after COVID-19 vaccination. Centers for Disease Control and Prevention; https://www.cdc.gov/coronavirus/2019-nc ... vents.html (2021).
3.
Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis. European Medicines Agency; https://www.ema.europa.eu/en/news/comir ... ricarditis (2021).
4.
Surveillance of myocarditis (inflammation of the heart muscle) cases between December 2020 and May 2021 (including). Ministry of Health of the Israeli Government; https://www.gov.il/en/departments/news/01062021-03 (2021).
5.
Petersen, I., Douglas, I. & Whitaker, H. Self controlled case series methods: an alternative to standard epidemiological study designs. Brit. Med. J. 354, i4515 (2016).
Article
6.
Farrington, C. P., Nash, J. & Miller, E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am. J. Epidemiol. 143, 1165–1173 (1996).
CAS

Article

7.
Pollack, A. et al. Viral myocarditis–diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 12, 670–680 (2015).
Article

8.
Fairweather, D., Cooper, L. T. & Blauwet, L. A. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr. Probl. Cardiol. 38, 7–46 (2013).
Article

9.
Chapman, A. R., Bularga, A. & Mills, N. L. High-sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation 141, 1733–1735 (2020).
CAS

Article

10.
Kociol, R. D. et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 141, e69–e92 (2020).
Article

11.
Friedrich, M. G. et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J. Am. Coll. Cardiol. 53, 1475–1487 (2009).
Article

12.
Ferreira, V. M. et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J. Am. Coll. Cardiol. 72, 3158–3176 (2018).
Article
13.
Pasupathy, S. et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131, 861–870 (2015).
CAS

Article
14.
Dastidar, A. G. et al. Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc. Imaging 12, 1973–1982 (2019).
Article

15.
Kim, J. Y., Han, K. & Suh, Y. J. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J. Cardiovasc. Magn. Reson. 23, 100 (2021).
CAS

Article

16.
Mei, R. et al. Myocarditis and pericarditis after immunization: gaining insights through the Vaccine Adverse Event Reporting System. Int. J. Cardiol. 273, 183–186 (2018).
Article

17.
Engler, R. J. et al. A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PLoS ONE 10, e0118283 (2015).
Article
18.
Dorward, D. A. et al. Tissue-specific immunopathology in fatal COVID-19. Am. J. Respir. Crit. Care Med. 203, 192–201 (2021).
CAS


19.
Bozkurt, B., Kamat, I. & Hotez, P. J. Myocarditis with COVID-19 mRNA vaccines. Circulation 144, 471–484 (2021).
CAS

Article

20.
Makunts, T. et al. Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data. Sci. Rep. 11, 17324 (2021).
CAS

Article

21.
Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med. 385, 1078–1090 (2021).
CAS

Article
22.
Witberg, G. et al. Myocarditis after Covid-19 vaccination in a large health care organization. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2110737 (2021).
23.
Mevorach, D. et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2109730 (2021).
24.
Simone, A. et al. Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2021.5511 (2021).
25.
Klein, N. P. et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326, 1390–1399 (2021).
CAS

Article
26.
Sandoval, Y., Januzzi, J. L. Jr. & Jaffe, A. S. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J. Am. Coll. Cardiol. 76, 1244–1258 (2020).
CAS

Article

27.
De Michieli, L. et al. High-sensitivity cardiac troponin T for the detection of myocardial injury and risk stratification in COVID-19. Clin. Chem. 67, 1080–1089 (2021).
Article

28.
Lala, A. et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J. Am. Coll. Cardiol. 76, 533–546 (2020).
CAS

Article

29.
Wilson, K. & Hawken, S. Drug safety studies and measures of effect using the self-controlled case series design. Pharmacoepidemiol. Drug Saf. 22, 108–110 (2013).
Article
30.
Fonseca-Rodríguez, O. et al. Avoiding bias in self-controlled case series studies of coronavirus disease 2019. Stat Med. 40, 6197–6208 (2021).
Article

31.
Lipsitch et al. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21, 383–388 (2010).
Article



32.
Kounis, N. G. Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines (Basel) 9, 221 (2021).
CAS

Article

Download references

Acknowledgements
This project involves data derived from patient-level information collected by the National Health Service (NHS), as part of the care and support of cancer patients. The SARS-Cov-2 test data are collated, maintained and quality assured by Public Health England (PHE). Access to the data was facilitated by the PHE Office for Data Release. The Hospital Episode Statistics, Secondary Users Service (SUS-PLUS) datasets and civil registration data are used by permission from NHS Digital who retain the copyright for that data. NHS Digital and PHE bear no responsibility for the analysis or interpretation of the data. K.K. is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC-EM) and NIHR Lifestyle BRC. M.S.-H. is supported by the National Institute for Health Research Clinician Scientist Award (NIHR-CS-2016-16-011). J.H.-C. and K.M.C. are supported by the NIHR Oxford Biomedical Research Centre. N.L.M. and K.M.C. are supported by the British Heart Foundation (Chair Awards CH/F/21/90010, CH/16/1/32013), Programme Grant (RG/20/10/34966) and Research Excellence Awards (RE/18/5/34216, RE18/3/34214). A.S. is supported by the Health Data Research United Kingdom BREATHE Hub. This research is part of the Data and Connectivity National Core Study, led by Health Data Research United Kingdom in partnership with the office of National Statistics and funded by United Kingdom Research and Innovation (grant MC_PC_20029). The investigators acknowledge the philanthropic support of the donors to the University of Oxford’s COVID-19 Research Response Fund. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the United Kingdom NIHR or the Department of Health. The funders of this study had no role in the design and conduct of the study and did not review or approve the manuscript. The views expressed are those of the authors and not necessarily the funders. M.P., J.H.-C. and C.A.C.C. had full access to all the study data and J.H.-C. had final responsibility for submission. This project is supported by a patient and public involvement advisory panel, which we thank for its continued support and guidance. The input of the panel has helped us identify priority questions for consideration and also supported analysis. Patient and Public Involvement and Engagement advisers were supportive of the vital importance of reporting on cardiac risks associated with both vaccination against COVID-19 and COVID-19 itself.

Author information
Affiliations
Nuffield Department of Primary Health Care Sciences, University of Oxford, Oxford, UK
Martina Patone, Xue W. Mei, Sharon Dixon, Anthony Harnden, Carol A. C. Coupland & Julia Hippisley-Cox

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK
Lahiru Handunnetthi

Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK
Francesco Zaccardi & Kamlesh Khunti

Usher Institute, University of Edinburgh, Edinburgh, UK
Manu Shankar-Hari, Nicholas L. Mills & Aziz Sheikh

Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
Manu Shankar-Hari

School of Immunology and Microbial Sciences, King’s College London, London, UK
Manu Shankar-Hari

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Peter Watkinson

NIHR Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, UK
Peter Watkinson

Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK
Carol A. C. Coupland

British Heart Foundation Centre of Research Excellence, NIHR Oxford Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Oxford, UK
Keith M. Channon

BHF/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
Nicholas L. Mills

Contributions
M.P., J.H.-C. and C.A.C.C. led the study conceptualization, development of the research question and analysis plan. J.H.-C. obtained funding, designed the analysis, obtained data approvals and contributed to interpretation of the analysis. M.P. undertook the data specification, curation, analysis. M.P. and N.L.M. wrote the first draft of the paper. S.D. undertook and reported on the Patient and Public Involvement and Engagement. L.H., K.M.C., F.Z., X.W.M., N.L.M., K.K., M.S.-H., P.W., A.H., S.D. and A.S. contributed to the discussion on protocol development and provided critical feedback on drafts of the manuscript. All authors approved the protocol, contributed to the critical revision of the manuscript and approved the final version of the manuscript.

Corresponding author
Correspondence to Julia Hippisley-Cox.

Ethics declarations
Competing interests
A.S. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group, the Scottish Government’s Standing Committee on Pandemics and AstraZeneca’s Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. J.H.-C. reports grants from NIHR Biomedical Research Centre, Oxford, John Fell Oxford University Press Research Fund and Cancer Research United Kingdom (CR-UK) grant no. C5255/A18085, through the CR-UK Oxford Centre, and grants from the Oxford Wellcome Institutional Strategic Support Fund (204826/Z/16/Z) and other research councils during the conduct of the study. J.H.-C. is an unpaid director of QResearch, a not-for-profit organization that is a partnership between the University of Oxford and EMIS Health who supplied the QResearch database used for this work. J.H.-C. is a founder and shareholder of ClinRisk Ltd and was its medical director until 31 May 2019. ClinRisk Ltd produces open and closed source software to implement clinical risk algorithms (outside this work) into clinical computer systems. J.H.-C. is chair of the NERVTAG risk stratification subgroup and a member of Scientific Advisory Group for Emergencies COVID-19 groups and the NHS group advising on prioritization of use of monoclonal antibodies in SARS-CoV-2 infection. A.H. is a member of the Joint Committee on Vaccination and Immunisation. K.K. is a member of the Governments Scientific Advisory Group for Emergencies. All other authors declare no competing interests related to this paper.

[Šabović Adis]

Imal ko od tih piejđdijeva da je nostrifikovo diplomu?

[insomnia]

Idemo ludo, idemo jako. Od ponedeljka u francuskoj djeca od 6 godina pa na dalje obavezna su nositi masku na javnim mjestima.
I jucer novi rekord, preko 200 000 pozitivnih. Zivjele vakcine

[Taare]

Idemo ludo, idemo jako. Od ponedeljka u francuskoj djeca od 6 godina pa na dalje obavezna su nositi masku na javnim mjestima.
I jucer novi rekord, preko 200 000 pozitivnih. Zivjele vakcine

Ja sam star i senilan pa sam zaboravio neke detalje. Možda mi možeš pomoći?
Kad su krenuli sa vakcinama, šta su ono govorili?
Men se čini da su spominjali neke slobode, ukidanje mjera za vakcinisane i sl.

[insomnia]

Idemo ludo, idemo jako. Od ponedeljka u francuskoj djeca od 6 godina pa na dalje obavezna su nositi masku na javnim mjestima.
I jucer novi rekord, preko 200 000 pozitivnih. Zivjele vakcine

Ja sam star i senilan pa sam zaboravio neke detalje. Možda mi možeš pomoći?
Kad su krenuli sa vakcinama, šta su ono govorili?
Men se čini da su spominjali neke slobode, ukidanje mjera za vakcinisane i sl.

Najbolje da se ko savjesni gradjani pozovemo ma rijec struke.
Francuski ministar zdravstva u svome govoru iz dvaescetvrtog jula.

Kada budemo vakcinisali 90-95% stanovnistva umjesto 20 000 pozitivnih imacemo 500 do 300 dnevno.

Francuska je jucer imala 208 000 pozitivnih.